-
1
-
-
0031038918
-
Alzheimer's disease: Genotypes, phenotype, and treatments
-
Selkoe D.J. Alzheimer's disease: genotypes, phenotype, and treatments. Science. 275:1997;630-631.
-
(1997)
Science
, vol.275
, pp. 630-631
-
-
Selkoe, D.J.1
-
2
-
-
0034718027
-
Biochemical detection of Aβ isoforms: Implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease
-
Golde T.E., Eckman C.B., Younkin S.G. Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim. Biophys. Acta. 1502:2000;172-187.
-
(2000)
Biochim. Biophys. Acta
, vol.1502
, pp. 172-187
-
-
Golde, T.E.1
Eckman, C.B.2
Younkin, S.G.3
-
3
-
-
0032491494
-
Genetic neurodegenerative diseases: The human illness and transgenic models
-
Price D.L., Sisodia S.S., Borchelt D.R. Genetic neurodegenerative diseases: the human illness and transgenic models. Science. 282:1998;1079-1083.
-
(1998)
Science
, vol.282
, pp. 1079-1083
-
-
Price, D.L.1
Sisodia, S.S.2
Borchelt, D.R.3
-
4
-
-
0028985574
-
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
-
Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
-
(1995)
Nature
, vol.373
, pp. 523-527
-
-
Games, D.1
Adams, D.2
Alessandrini, R.3
Barbour, R.4
Berthelette, P.5
Blackwell, C.6
Carr, T.7
Clemens, J.8
Donaldson, T.9
Gillespie, F.10
Guido, T.11
Hagopian, S.12
Johnson-Wood, K.13
Khan, K.14
Lee, M.15
Leibowitz, P.16
Lieberburg, I.17
Little, S.18
Masliah, E.19
McConlogue, L.20
Montoya-Zavala, M.21
Mucke, L.22
Paganini, L.23
Penniman, E.24
Power, M.25
Schenk, D.26
Seubert, P.27
Snyder, B.28
Soriano, F.29
Tan, H.30
Vitale, J.31
Wadsworth, S.32
Wolozin, B.33
Zhao, J.34
more..
-
5
-
-
0029742199
-
Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
-
Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
-
(1996)
Science
, vol.274
, pp. 99-102
-
-
Hsiao, K.1
Chapman, P.2
Nilsen, S.3
Eckman, C.4
Harigaya, Y.5
Younkin, S.6
Yang, F.7
Cole, G.8
-
6
-
-
0030833055
-
Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins
-
Borchelt D.R., Ratovitski T., Van Lare J., Lee M.K., Gonzales V.B., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
-
(1997)
Neuron
, vol.19
, pp. 939-945
-
-
Borchelt, D.R.1
Ratovitski, T.2
Van Lare, J.3
Lee, M.K.4
Gonzales, V.B.5
Jenkins, N.A.6
Copeland, N.G.7
Price, D.L.8
Sisodia, S.S.9
-
7
-
-
0031914718
-
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
-
Holcomb L.A., Gordon M.N., McGowan E., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Yu X., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.-M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nature Med. 4:1998;97-100.
-
(1998)
Nature Med.
, vol.4
, pp. 97-100
-
-
Holcomb, L.A.1
Gordon, M.N.2
McGowan, E.3
Benkovic, S.4
Jantzen, P.5
Wright, K.6
Saad, I.7
Mueller, R.8
Morgan, D.9
Yu, X.10
Sanders, S.11
Zehr, C.12
O'Campo, K.13
Hardy, J.14
Prada, C.-M.15
Eckman, C.16
Younkin, S.17
Hsiao, K.18
Duff, K.19
-
8
-
-
0031278270
-
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
-
Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E., Little S., Cummins D., Piccardo P., Ghetti B., Black S.M. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet. 17:1997;263-264.
-
(1997)
Nature Genet.
, vol.17
, pp. 263-264
-
-
Bales, K.R.1
Verina, T.2
Dodel, R.C.3
Du, Y.4
Altstiel, L.5
Bender, M.6
Hyslop, P.7
Johnstone, E.8
Little, S.9
Cummins, D.10
Piccardo, P.11
Ghetti, B.12
Black, S.M.13
-
9
-
-
4243215848
-
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
-
Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 97:2000;2892-2897.
-
(2000)
Proc. Natl. Acad. Sci. USA
, vol.97
, pp. 2892-2897
-
-
Holtzman, D.M.1
Bales, K.R.2
Tenkova, T.3
Fagan, A.M.4
Parsadanian, M.5
Sartorius, L.J.6
Mackey, B.7
Olney, J.8
McKeel, D.9
Wozniak, D.10
Paul, S.M.11
-
10
-
-
0033536163
-
Immunization with amyloid-attenuates Alzheimer-disease-like pathology in the PDAPP mouse
-
Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburb I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
-
(1999)
Nature
, vol.400
, pp. 173-177
-
-
Schenk, D.1
Barbour, R.2
Dunn, W.3
Gordon, G.4
Grajeda, H.5
Guido, T.6
Hu, K.7
Huang, J.8
Johnson-Wood, K.9
Khan, K.10
Kholodenko, D.11
Lee, M.12
Liao, Z.13
Lieberburb, I.14
Motter, R.15
Mutter, L.16
Soriano, F.17
Shopp, G.18
Vasquez, N.19
Vandevert, C.20
Walker, S.21
Wogulis, M.22
Yednock, T.23
Games, D.24
Seubert, P.25
more..
-
11
-
-
0033835996
-
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease
-
Bard F., Cannon C., Barbour R., Burke R.-L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nature Med. 6:2000;916-919.
-
(2000)
Nature Med.
, vol.6
, pp. 916-919
-
-
Bard, F.1
Cannon, C.2
Barbour, R.3
Burke, R.-L.4
Games, D.5
Grajeda, H.6
Guido, T.7
Hu, K.8
Huang, J.9
Johnson-Wood, K.10
Khan, K.11
Kholodenko, D.12
Lee, M.13
Lieberburg, I.14
Motter, R.15
Nguyen, M.16
Soriano, F.17
Vasquez, N.18
Weiss, K.19
Welch, B.20
Seubert, P.21
Schenk, D.22
Yednock, T.23
more..
-
12
-
-
0035902619
-
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
-
DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.-C., Paul S.M., Holtzman D.M. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 98:2001;8850-8855.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 8850-8855
-
-
DeMattos, R.B.1
Bales, K.R.2
Cummins, D.J.3
Dodart, J.-C.4
Paul, S.M.5
Holtzman, D.M.6
-
13
-
-
0031020909
-
Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer's disease
-
Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1555.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 1550-1555
-
-
Johnson-Wood, K.1
Lee, M.2
Motter, R.3
Hu, K.4
Gordon, G.5
Barbour, R.6
Khan, K.7
Gordon, M.8
Tan, H.9
Games, D.10
Lieberburg, I.11
Schenk, D.12
Seubert, P.13
McConlogue, L.14
-
14
-
-
0034107615
-
Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice
-
Dodart J.C., Mathis C., Saura J., Bales K.R., Paul S.M., Ungerer A. Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice. Neurobiol. Dis. 7:2000;71-85.
-
(2000)
Neurobiol. Dis.
, vol.7
, pp. 71-85
-
-
Dodart, J.C.1
Mathis, C.2
Saura, J.3
Bales, K.R.4
Paul, S.M.5
Ungerer, A.6
-
15
-
-
0034700480
-
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
-
Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J., Justice A., McConlogue L., Games D., Freedman S.B., Morris R.G. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000;975-979.
-
(2000)
Nature
, vol.408
, pp. 975-979
-
-
Chen, G.1
Chen, K.S.2
Knox, J.3
Inglis, J.4
Bernard, A.5
Martin, S.J.6
Justice, A.7
McConlogue, L.8
Games, D.9
Freedman, S.B.10
Morris, R.G.11
-
16
-
-
0030612033
-
APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1
-
Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropath. Exp. Neurol. 56:1997;965-973.
-
(1997)
J. Neuropath. Exp. Neurol.
, vol.56
, pp. 965-973
-
-
Irizarry, M.C.1
McNamara, M.2
Fedorchak, K.3
Hsiao, K.4
Hyman, B.T.5
-
17
-
-
0030611097
-
Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse
-
Irizarry M.C., Soriano F., McNamara M., Page K.J., Schenk D., Games D., Hyman B.T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
-
(1997)
J. Neurosci.
, vol.17
, pp. 7053-7059
-
-
Irizarry, M.C.1
Soriano, F.2
McNamara, M.3
Page, K.J.4
Schenk, D.5
Games, D.6
Hyman, B.T.7
-
18
-
-
0029813177
-
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease
-
Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
-
(1996)
J. Neurosci.
, vol.16
, pp. 5795-5811
-
-
Masliah, E.1
Sisk, A.2
Mallory, M.3
Mucke, L.4
Schenk, D.5
Games, D.6
-
19
-
-
0031981072
-
Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress
-
Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L., Siedlak S.L., Tabaton M., Perry G. Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem. 70:1998;2212-2215.
-
(1998)
J. Neurochem.
, vol.70
, pp. 2212-2215
-
-
Smith, M.A.1
Hirai, K.2
Hsiao, K.3
Pappolla, M.A.4
Harris, P.L.5
Siedlak, S.L.6
Tabaton, M.7
Perry, G.8
-
20
-
-
0031974406
-
Microglial response to amyloid plaques in APPsw transgenic mice
-
Frautschy S.A., Yang F., Irizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317.
-
(1998)
Am. J. Pathol.
, vol.152
, pp. 307-317
-
-
Frautschy, S.A.1
Yang, F.2
Irizarry, M.3
Hyman, B.4
Saido, T.C.5
Hsiao, K.6
Cole, G.M.7
-
21
-
-
0011469238
-
Age-dependent deficits in spatial memory and hippocampal LTP in vivo in APP transgenic mice
-
Jones M.W., Bliss T.V.P., Hsiao K.K., Chapman P.F. Age-dependent deficits in spatial memory and hippocampal LTP in vivo in APP transgenic mice. Soc. Neurosci. Abstr. 24:1998;729.
-
(1998)
Soc. Neurosci. Abstr.
, vol.24
, pp. 729
-
-
Jones, M.W.1
Bliss, T.V.P.2
Hsiao, K.K.3
Chapman, P.F.4
-
22
-
-
2242470701
-
Overexpression of mutant β-amyloid precursor protein severely attenuates hippocampal synaptic transmission in an Alzheimer's disease mouse model
-
Hsia A.Y., Mucke L., Malenka R.C., Nicoll R.A. Overexpression of mutant β-amyloid precursor protein severely attenuates hippocampal synaptic transmission in an Alzheimer's disease mouse model. Soc. Neurosci. Abstr. 24:1998;729.
-
(1998)
Soc. Neurosci. Abstr.
, vol.24
, pp. 729
-
-
Hsia, A.Y.1
Mucke, L.2
Malenka, R.C.3
Nicoll, R.A.4
-
23
-
-
0034918436
-
Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: Implications for neural system disruption
-
Le R., Cruz L., Urbanc B., Knowles R.B., Hsiao-Ashe K., Duff K., Irizarry M.C., Stanley H.E., Hyman B.T. Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption. J. Neuropathol. Exp. Neurol. 60:2001;753-758.
-
(2001)
J. Neuropathol. Exp. Neurol.
, vol.60
, pp. 753-758
-
-
Le, R.1
Cruz, L.2
Urbanc, B.3
Knowles, R.B.4
Hsiao-Ashe, K.5
Duff, K.6
Irizarry, M.C.7
Stanley, H.E.8
Hyman, B.T.9
-
24
-
-
0035863055
-
Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease
-
Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21:2001;372-381.
-
(2001)
J. Neurosci.
, vol.21
, pp. 372-381
-
-
Kawarabayashi, T.1
Younkin, L.H.2
Saido, T.C.3
Shoji, M.4
Ashe, K.H.5
Younkin, S.G.6
-
25
-
-
11544279355
-
Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
-
Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:1998;6448-6453.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 6448-6453
-
-
Lambert, M.P.1
Barlow, A.K.2
Chromy, B.A.3
Edwards, C.4
Freed, R.5
Liosatos, M.6
Morgan, T.E.7
Rozovsky, I.8
Trommer, B.9
Viola, K.L.10
Wals, P.11
Zhang, C.12
Finch, C.E.13
Krafft, G.A.14
Klein, W.L.15
-
26
-
-
0011444914
-
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
-
Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292.
-
(1997)
Proc. Natl. Acad. Sci. USA
, vol.94
, pp. 13287-13292
-
-
Sturchler-Pierrat, C.1
Abramowski, D.2
Duke, M.3
Wiederhold, K.-H.4
Mistl, C.5
Rothacher, S.6
Ledermann, B.7
Burki, K.8
Frey, P.9
Paganetti, P.A.10
Waridel, C.11
Calhoun, M.E.12
Jucker, M.13
Probst, A.14
Staufenbiel, M.15
Sommer, B.16
-
27
-
-
0034213718
-
High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation
-
Mucke L., Masliah E., Yu G.-Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of Aβ1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20:2001;4050-4058.
-
(2001)
J. Neurosci.
, vol.20
, pp. 4050-4058
-
-
Mucke, L.1
Masliah, E.2
Yu, G.-Q.3
Mallory, M.4
Rockenstein, E.M.5
Tatsuno, G.6
Hu, K.7
Kholodenko, D.8
Johnson-Wood, K.9
McConlogue, L.10
-
28
-
-
0034700471
-
Aβ peptide immunization reduced behavioural impairment and plaques in a model of Alzheimer' s disease
-
Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., StGeorge-Hyslop P., Westaway D. Aβ peptide immunization reduced behavioural impairment and plaques in a model of Alzheimer' s disease. Nature. 408:2000;979-982.
-
(2000)
Nature
, vol.408
, pp. 979-982
-
-
Janus, C.1
Pearson, J.2
McLaurin, J.3
Mathews, P.M.4
Jiang, Y.5
Schmidt, S.D.6
Chishti, M.A.7
Horne, P.8
Heslin, D.9
French, J.10
Mount, H.T.11
Nixon, R.A.12
Mercken, M.13
Bergeron, C.14
Fraser, P.E.15
StGeorge-Hyslop, P.16
Westaway, D.17
-
29
-
-
0344431341
-
Structural neurology: Are seeds at the root of neuronal degeneration
-
Lansbury P.T.J. Structural neurology: are seeds at the root of neuronal degeneration. Neuron. 19:1997;1151-1154.
-
(1997)
Neuron
, vol.19
, pp. 1151-1154
-
-
Lansbury, P.T.J.1
-
30
-
-
0033616587
-
In situ AFM study of Alzheimer's β-amyloid peptide on different substrates: New insights into mechanism of β sheet formation
-
Kowalewski T., Holtzman D.M. In situ AFM study of Alzheimer's β-amyloid peptide on different substrates: new insights into mechanism of β sheet formation. Proc. Natl. Acad. Sci USA. 96:1999;3688-3693.
-
(1999)
Proc. Natl. Acad. Sci USA
, vol.96
, pp. 3688-3693
-
-
Kowalewski, T.1
Holtzman, D.M.2
-
32
-
-
0033593027
-
Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease
-
Bales K.R., Verina T., Cummins D.J., Du Y., Dodel R.C., Saura J., Fishman C.E., DeLong C.A., Piccardo P., Petegnief V., Ghetti B., Paul S.M. Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 96:1999;15233-15238.
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 15233-15238
-
-
Bales, K.R.1
Verina, T.2
Cummins, D.J.3
Du, Y.4
Dodel, R.C.5
Saura, J.6
Fishman, C.E.7
DeLong, C.A.8
Piccardo, P.9
Petegnief, V.10
Ghetti, B.11
Paul, S.M.12
-
33
-
-
0034123538
-
ApoE facilitates neuritic and cerebrovascular plaque formation in the APPsw mouse model of Alzheimer's disease
-
Holtzman D.M., Fagan A.M., Mackey B., Tenkova T., Sartorius L., Paul S.M., Bale K., Ashe K.H., Irizzary M.C., Hyman B.T. ApoE facilitates neuritic and cerebrovascular plaque formation in the APPsw mouse model of Alzheimer's disease. Ann. Neurol. 47:2000;739-747.
-
(2000)
Ann. Neurol.
, vol.47
, pp. 739-747
-
-
Holtzman, D.M.1
Fagan, A.M.2
Mackey, B.3
Tenkova, T.4
Sartorius, L.5
Paul, S.M.6
Bale, K.7
Ashe, K.H.8
Irizzary, M.C.9
Hyman, B.T.10
-
34
-
-
0033801852
-
Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease
-
Weiner H.L., Lemere C.A., Maron R., Spooner E.T., Grenfell T.J., Mori C., Issazadeh S., Hancock W.W., Selkoe D.J. Nasal administration of amyloid-β peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 48:2000;567-579.
-
(2000)
Ann. Neurol.
, vol.48
, pp. 567-579
-
-
Weiner, H.L.1
Lemere, C.A.2
Maron, R.3
Spooner, E.T.4
Grenfell, T.J.5
Mori, C.6
Issazadeh, S.7
Hancock, W.W.8
Selkoe, D.J.9
-
35
-
-
0034884382
-
Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice
-
Sigurdsson E.M., Scholtzova H., Mehta P., Frangione B., Wisniewski T. Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am. J. Pathol. 159:2001;439-447.
-
(2001)
Am. J. Pathol.
, vol.159
, pp. 439-447
-
-
Sigurdsson, E.M.1
Scholtzova, H.2
Mehta, P.3
Frangione, B.4
Wisniewski, T.5
-
36
-
-
84984755327
-
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
-
Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Conner K., Hatcher J., Hope C., Gordon M., Arendash G.W. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
-
(2000)
Nature
, vol.408
, pp. 982-985
-
-
Morgan, D.1
Diamond, D.M.2
Gottschall, P.E.3
Ugen, K.E.4
Dickey, C.5
Hardy, J.6
Duff, K.7
Jantzen, P.8
DiCarlo, G.9
Wilcock, D.10
Conner, K.11
Hatcher, J.12
Hope, C.13
Gordon, M.14
Arendash, G.W.15
-
37
-
-
84892034887
-
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease (correction)
-
Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Conner K., Hatcher J., Hope C., Gordon M., Arendash G.W. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease (correction). Nature. 412:2001;660.
-
(2001)
Nature
, vol.412
, pp. 660
-
-
Morgan, D.1
Diamond, D.M.2
Gottschall, P.E.3
Ugen, K.E.4
Dickey, C.5
Hardy, J.6
Duff, K.7
Jantzen, P.8
DiCarlo, G.9
Wilcock, D.10
Conner, K.11
Hatcher, J.12
Hope, C.13
Gordon, M.14
Arendash, G.W.15
-
38
-
-
0035106780
-
Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
-
Backsai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P., Schenk D., Hyman B.T. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nature Med. 7:2001;369-372.
-
(2001)
Nature Med.
, vol.7
, pp. 369-372
-
-
Backsai, B.J.1
Kajdasz, S.T.2
Christie, R.H.3
Carter, C.4
Games, D.5
Seubert, P.6
Schenk, D.7
Hyman, B.T.8
-
39
-
-
2242480590
-
Multiple mechanisms are involved in clearance of amyloid-β by immunotherapy
-
Backsai B.J., Kajdasz S.T., McLellen M.E., Games D., Seubert P., Schenk D., Hyman B.T. Multiple mechanisms are involved in clearance of amyloid-β by immunotherapy. Soc. Neurosci. Abstr. 27:2001;687.7.
-
(2001)
Soc. Neurosci. Abstr.
, vol.27
, pp. 6877
-
-
Backsai, B.J.1
Kajdasz, S.T.2
McLellen, M.E.3
Games, D.4
Seubert, P.5
Schenk, D.6
Hyman, B.T.7
-
41
-
-
0032995727
-
Receptor-mediated transport of human amyloidβ protein 1-40 and 1-42 at the blood-brain barrier
-
Poduslo J.F., Curran G.L., Sanyal B., Selkoe D.J. Receptor-mediated transport of human amyloidβ protein 1-40 and 1-42 at the blood-brain barrier. Neurobiol. Dis. 6:1999;190-199.
-
(1999)
Neurobiol. Dis.
, vol.6
, pp. 190-199
-
-
Poduslo, J.F.1
Curran, G.L.2
Sanyal, B.3
Selkoe, D.J.4
-
42
-
-
0035968932
-
Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier
-
Poduslo J.F., Curran G.L. Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier. NeuroReport. 12:2001;3197-3200.
-
(2001)
NeuroReport
, vol.12
, pp. 3197-3200
-
-
Poduslo, J.F.1
Curran, G.L.2
-
43
-
-
0030035294
-
Fate of cerebrospinal fluid-borne amyloid β-peptide: Rapid clearance into blood and appreciable accumulation by cerebral arteries
-
Ghersi-Egea J.F., Gorevic P.D., Ghiso J., Frangione B., Patlak C.S., Fensternacher J.D. Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem. 67:1996;880-883.
-
(1996)
J. Neurochem.
, vol.67
, pp. 880-883
-
-
Ghersi-Egea, J.F.1
Gorevic, P.D.2
Ghiso, J.3
Frangione, B.4
Patlak, C.S.5
Fensternacher, J.D.6
-
44
-
-
0034521392
-
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
-
Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Berislav B.L. Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106:2000;1489-1499.
-
(2000)
J. Clin. Invest.
, vol.106
, pp. 1489-1499
-
-
Shibata, M.1
Yamada, S.2
Kumar, S.R.3
Calero, M.4
Bading, J.5
Frangione, B.6
Holtzman, D.M.7
Miller, C.A.8
Strickland, D.K.9
Ghiso, J.10
Berislav, B.L.11
-
45
-
-
0035082722
-
Amyloid β40/42 clearance across the blood-brain barrier following intraventricular injections in wild-type, apoE knockout and human apoE3 or E4 expressing transgenic mice
-
Ji Y., Permanne B., Sigurdsson E.M., Holtzman D.M., Wisniewski T. Amyloid β40/42 clearance across the blood-brain barrier following intraventricular injections in wild-type, apoE knockout and human apoE3 or E4 expressing transgenic mice. J. Alzheimer's Dis. 3:2001;23-30.
-
(2001)
J. Alzheimer's Dis.
, vol.3
, pp. 23-30
-
-
Ji, Y.1
Permanne, B.2
Sigurdsson, E.M.3
Holtzman, D.M.4
Wisniewski, T.5
-
46
-
-
0003181672
-
Aβ immunization of PSAPP mice leads to decreased cerebral Aβ and a corresponding increase in serum Aβ
-
Lemere C.A., Spooner E.T., Malester B., LaFrancois J., Mori C., Leverone J.F., Clements J.T., Selkoe D.J., Duff K.E. Aβ immunization of PSAPP mice leads to decreased cerebral Aβ and a corresponding increase in serum Aβ Soc. Neurosci. Abstr. 27:2001;687.10.
-
(2001)
Soc. Neurosci. Abstr.
, vol.27
, pp. 68710
-
-
Lemere, C.A.1
Spooner, E.T.2
Malester, B.3
LaFrancois, J.4
Mori, C.5
Leverone, J.F.6
Clements, J.T.7
Selkoe, D.J.8
Duff, K.E.9
-
47
-
-
0035979145
-
Aβ immunization: Moving Aβ peptide from brain to blood
-
Lee V.M.-Y. Aβ immunization: moving Aβ peptide from brain to blood. Proc. Natl. Acad. Sci. USA. 98:2001;8931-8932.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 8931-8932
-
-
Lee, V.M.-Y.1
-
48
-
-
0036319503
-
Plaque-associated disruption of CSF and plasma Aβ equilibrium in a mouse model of Alzheimer's disease
-
DeMattos R.B., Bales K.R., Parsadanian M., O'Dell M.A., Foss E.M., Paul S.M., Holtzman D.M. Plaque-associated disruption of CSF and plasma Aβ equilibrium in a mouse model of Alzheimer's disease. J. Neurochem. 81:2002;229-236.
-
(2002)
J. Neurochem.
, vol.81
, pp. 229-236
-
-
DeMattos, R.B.1
Bales, K.R.2
Parsadanian, M.3
O'Dell, M.A.4
Foss, E.M.5
Paul, S.M.6
Holtzman, D.M.7
-
49
-
-
2242468850
-
V717F transgenic mice
-
V717F transgenic mice. Soc. Neurosci. Abstr. 27:2001;687.12.
-
(2001)
Soc. Neurosci. Abstr.
, vol.27
, pp. 68712
-
-
Dodart, J.-C.1
Bales, K.R.2
DeMattos, R.B.3
Mathias, C.4
Delong, C.A.5
Wu, X.6
Holtzman, D.M.7
Paul, S.M.8
-
50
-
-
0035899413
-
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
-
Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Burton D.R., Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:2001;739-743.
-
(2001)
Nature
, vol.412
, pp. 739-743
-
-
Peretz, D.1
Williamson, R.A.2
Kaneko, K.3
Vergara, J.4
Leclerc, E.5
Mehlhorn, I.R.6
Legname, G.7
Wormald, M.R.8
Rudd, P.M.9
Burton, D.R.10
Prusiner, S.B.11
|